Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Stock Price Down 8.3
published 31.07.2020 15:26
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States.
Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) last released its quarterly earnings data on Wednesday, May 6th.
Separately, Zacks Investment Research lowered Ampio Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, June 9th.
Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) dropped 8.3% on Wednesday .